Fri, February 10, 2023
Thu, February 9, 2023
Wed, February 8, 2023

Robyn Karnauskas Reiterated (ABBV) at Strong Buy and Held Target at $180 on, Feb 9th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-180-on-feb-9th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Robyn Karnauskas of Truist Securities, Reiterated "AbbVie Inc." (ABBV) at Strong Buy and Held Target at $180 on, Feb 9th, 2023.

Robyn has made no other calls on ABBV in the last 4 months.



There are 10 other peers that have a rating on ABBV. Out of the 10 peers that are also analyzing ABBV, 6 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Navin Jacob of "UBS" Maintained at Hold with Increased Target to $150 on, Tuesday, January 31st, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022
  • Navaan Ty of "Exane BNP Paribas" Initiated at Hold and Held Target at $169 on, Thursday, December 8th, 2022
  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022


These are the ratings of the 4 analyists that currently disagree with Robyn


  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $167 on, Monday, February 6th, 2023
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $157 on, Tuesday, January 17th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $182 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022

Publication Contributing Sources